Histone Deacetylase Inhibitors Demonstrate Significant Preclinical Activity as Single Agents, and in Combination with Bortezomib in Waldenström's MacroglobulinemiaShow More
Clinical Lymphoma Myeloma and Leukemia , Volume 11, pp 152-156; doi:10.3816/clml.2011.n.036
The publisher has not yet granted permission to display this abstract.
Keywords: bone marrow / Macroglobulinemia / Hdac9 / apoptosis / gene expression / Treatment / bortezomib / inhibitors / Overexpression / Deacetylase
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Clinical Lymphoma Myeloma and Leukemia" .